Sepsis and Septic Shock Strategies

Surgical Clinics of North America

Volumn 97, Issue 6, 2017, Pages 1339-1379

  Armstrong, Bracken A ^a   Betzold, Richard D ^a   May, Addison K ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Critical care; Goal directed therapy; Resuscitation; Sepsis; Septic shock

Indexed keywords

ACUTE PHASE PROTEIN; AMIODARONE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; CHEMOKINE; CISATRACURIUM; CORTICOSTEROID DERIVATIVE; CYTOKINE; DIGOXIN; DOBUTAMINE; DOPAMINE; EPINEPHRINE; HEMOGLOBIN; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; NORADRENALIN; OMEGA 3 FATTY ACID; PATTERN RECOGNITION RECEPTOR; PHENYLEPHRINE; PLACEBO; TRANSCRIPTION FACTOR; UNINDEXED DRUG; VASOACTIVE AGENT; VASOPRESSIN; XANTHINE OXIDASE; OXYGEN; VASODILATOR AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIMICROBIAL THERAPY; ARTIFICIAL VENTILATION; ATRIAL FIBRILLATION; BRAIN DISEASE; CARDIOMYOPATHY; CENTRAL VENOUS PRESSURE; CRITICAL ILLNESS; DELIRIUM; DRUG POTENTIATION; ENTERIC FEEDING; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; EXTRACORPOREAL OXYGENATION; FLUID RESUSCITATION; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; INTERMETHOD COMPARISON; LACTIC ACIDOSIS; MEAN ARTERIAL PRESSURE; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; OVERALL SURVIVAL; OXIDATIVE STRESS; OXYGEN SATURATION; PARENTERAL NUTRITION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC CARDIOMYOPATHY; SEPTIC ENCEPHALOPATHY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TACHYCARDIA; TREATMENT RESPONSE; ARTERIAL PRESSURE; BLOOD; INTENSIVE CARE; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PATIENT CARE PLANNING; PHYSIOLOGY; PROCEDURES; RESUSCITATION; SEPSIS ASSOCIATED ENCEPHALOPATHY; SEVERITY OF ILLNESS INDEX;

ANTI-BACTERIAL AGENTS; ARTERIAL PRESSURE; CARDIOMYOPATHIES; CENTRAL VENOUS PRESSURE; CRITICAL CARE; DELIRIUM; HEMOGLOBINS; HUMANS; LACTIC ACID; OXYGEN; PATIENT CARE PLANNING; PROGNOSIS; RESUSCITATION; SEPSIS; SEPSIS-ASSOCIATED ENCEPHALOPATHY; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; VASODILATOR AGENTS;

EID: 85030543679     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2017.07.003     Document Type: Review

References (308)

1. Wang, H.E., Shapiro, N.I., Angus, D.C., et al. National estimates of severe sepsis in United States emergency departments. Crit Care Med 35:8 (2007), 1928–1936.
2. Lagu, T., Rothberg, M.B., Shieh, M.S., et al. Hospitalizations, costs, outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 40 (2012), 754–756 [Erratum appears in Crit Care Med 2012;40:2932].
3. Torio, C., Moore, B., National inpatient hospital costs: the most expensive conditions by payer, 2013. HCUP statistical brief #204. 2016, Agency for Healthcare Research and Quality, Rockville (MD).
4. Martin, G.S., Mannino, D.M., Eaton, S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:16 (2003), 1546–1554.
5. Dombrovskiy, V.Y., Martin, A.A., Sunderram, J., et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35 (2007), 1244–1250.
6. Kaukonen, J.M., Bailey, M., Suzuki, S., et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 311:13 (2014), 1308–1316.
7. Liu, V., Escobar, G.J., Greene, J.D., et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 312:1 (2014), 90–91.
8. Bone, R.C., Balk, R.A., Cerra, F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992), 1644–1655.
9. Levy, M.M., Fink, M.P., Marshal, J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (2003), 1250–1256.
10. Singer, M., Deutschman, C.S., Seymor, C.W., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:8 (2016), 801–810.
11. Vincent, J.L., Moreno, R., Takala, J., et al., Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:7 (1996), 707–710.
12. Vincent, J.L., de Mendonca, A., Cantraine, F., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working Group on “Sepsis-Related Problems” of the European Society of Intensive Care Medicine. Crit Care Med 26:11 (1998), 1793–1800.
13. Seymour, C.W., Liu, V.X., Iwashyna, T.J., et al. Assessment of clinical criteria for sepsis for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:8 (2016), 762–774.
14. Shankar-Hari, M., Phillips, G.S., Levy, M.L., et al. Developing a new definition and assessing new clinical criteria for septic shock for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315 (2016), 775–787.
15. Ferreira, F.L., Bota, D.P., Bross, A., et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286:14 (2001), 1754–1758.
16. Kaukonen, K.M., Bailey, M., Pilcher, D., et al. Systemic inflammatory response syndrome criteria in defining sepsis. N Engl J Med 372:17 (2015), 1629–1638.
17. Rhee, C., Gohil, S., Klompas, M., Regulatory mandates for sepsis care-reasons for caution. N Engl J Med 370:18 (2014), 1673–1676.
18. Crabtree, T.D., Pelletier, S.J., Antevil, J.L., et al. Cohort study of fever and leukocytosis as diagnostic and prognostic indicators in infected surgical patients. World J Surg 25 (2001), 739–744.
19. Rangel-Frasto, M.S., Pittet, D., Costigan, M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273 (1995), 117–123.
20. Sprung, C.L., Sakr, Y., Vincent, J.L., et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Intensive Care Med 32 (2006), 421–427.
21. Dulhunty, J.M., Lipman, J., Finfer, S., Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand intensive care unit study. Intensive Care Med 34 (2008), 1654–1661.
22. Churpek, M.M., Zadravecz, F.J., Winslow, C., et al. Incidence and prognosis value of the systemic inflammatory response syndrome and organ dysfunctions in ward patients. Am J Respir Crit Care Med 192 (2015), 958–964.
23. Hotchkiss, R.S., Monneret, G., Payen, D., Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:12 (2013), 862–874.
24. Delano, M.J., Ward, P.A., The immune system's role in sepsis progression, resolution, and long-term outcome. Immunol Rev 274 (2016), 330–353.
25. Angus, D.C., van der Poll, T., Severe sepsis and septic shock. N Engl J Med 369:9 (2013), 840–851.
26. Cinel, I., Opal, S.M., Molecular biology of inflammation and sepsis: a primer. Crit Care Med 37:1 (2009), 291–304.
27. Deutschman, C.S., Tracey, K.J., Sepsis: current dogma and new perspectives. Immunity 40:4 (2014), 463–475.
28. Singer, M., De Santis, V., Vitale, D., et al. Multiorgan failure is an adaptive, endocrine mediated, metabolic response to overwhelming systemic inflammation. Lancet 364:9433 (2004), 545–548.
29. Nduka, O.O., Parillo, J.E., The pathophysiology of septic shock. Crit Care Clin 25 (2009), 677–702.
30. Abraham, E., Singer, M., Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35:10 (2007), 2408–2416.
31. Singer, M., The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 5:1 (2014), 66–72.
32. Andrades, M.E., Morina, A., Spasic, S., et al. Bench-to-bedside review: sepsis—from the redox point of view. Crit Care 15:230 (2011), 1–12.
33. Raith, E.P., Udy, A.A., Baily, M., et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA 317:3 (2017), 290–300.
34. Vincent, J.L., Martin, G.S., Levy, M.M., qSOFA does not replace SIRS in the definition of sepsis. Crit Care, 20, 2016, 210.
35. April, M.D., Aguire, J., Tannenbaum, L.I., et al. Sepsis clinical criteria in emergency department patients admitted to an intensive care unit: an external validation study of quick sequential organ failure assessment. J Emerg Med 52:5 (2016), 622–631 Accessed March 10, 2017.
36. Williams, J.M., Greenslade, J.H., McKenzie, J.V., et al. Systemic inflammatory response syndrome, quick sequential organ dysfunction assessment, and organ dysfunction: insights from a prospective database of ED patients with infection. Chest 151:3 (2017), 586–596.
37. Freund, Y., Lemachatti, N., Krastinova, E., et al. Prognostic accuracy of Sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA 317:3 (2017), 301–308.
38. Churpek, M.M., Snyder, A.S., Han, X., et al. qSOFA, SIRS, and early warning scores for detecting clinical deterioration in infected patients outside the ICU. Am J Respir Crit Care Med 195:7 (2016), 906–911 Accessed March 10, 2017.
39. Smith, G.B., Prytherch, D.R., Meredith, P., et al. The ability of the national early warning score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission and death. Resuscitation 84 (2013), 465–470.
40. Royal College of Physicians, National early warning score (NEWS): standardising the assessment of acute illness severity in the NHS. 2012, Royal College of Physicians, London.
41. Jones, D.A., DeVita, M.A., Bellomo, R., Rapid-response teams. N Engl J Med 365 (2011), 139–146.
42. Smith, M.E., Chiovaro, J.C., O'Neil, M., et al. Early warning system scores for clinical deterioration in hospitalized patients: a systematic review. Ann Am Thorac Soc 11 (2014), 1454–1465.
43. Vincent, J.L., The challenge of early identification of the hospital patient at risk of septic complications. Ann Transl Med, 5(3), 2017, 56.
44. McLymont, N., Glover, G.W., Scoring systems for the characterization of sepsis and associated outcomes. Ann Transl Med, 4(24), 2016, 527.
45. Simpson, S.Q., New sepsis criteria: a change we should not make. Chest 149 (2016), 1117–1118.
46. Cortes-Puch, I., Hartog, C.S., Opening the debate on the new sepsis definition change is not necessarily progress: revision of the sepsis definition should be based on new scientific insights. Am J Respir Crit Care Med 194:1 (2016), 16–18.
47. Simpson, S.Q., Diagnosing sepsis: a step forward, and possibly a step back. Ann Transl Med, 5(3), 2017, 55.
48. Rivers, E., Nguyen, B., Havstad, S., et al., The Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001), 1368–1377.
49. Kumar, A., Roberts, D., Wood, K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006), 1589–1596.
50. Levy, M.M., Dellinger, R.P., Townsend, S.R., et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 36 (2010), 222–231.
51. Azuhata, T., Kinoshita, K., Kawano, D., et al. Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care, 18, 2014, R87.
52. Wong, C.H., Chang, H.C., Pasupathy, S., et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85:8 (2003), 1454–1460.
53. Liu, Y.M., Chi, C.Y., Ho, M.W., et al. Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect 38:6 (2005), 430–435.
54. Golger, A., Ching, S., Goldsmith, C.H., et al. Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg 119:6 (2007), 1803–1807.
55. Zadroga, R., Williams, D.N., Gottschall, R., et al. Comparison of 2 blood culture media shows significant differences in bacterial recovery for patients on antimicrobial therapy. Clin Infect Dis 56 (2013), 790–797.
56. Weinstein, M.P., Reller, L.B., Murphy, J.R., et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 5 (1983), 35–53.
57. Cardoso, T., Carneiro, A.H., Ribeiro, O., et al. Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study). Crit Care, 14, 2010, R83.
58. De Sousa, A.G., Fernandes Junior, C.J., Santos, G.P.D., et al. The impact of each action in the Surviving Sepsis Campaign measures on hospital mortality of patients with severe sepsis/septic chosk. Einstein 6:3 (2008), 323–327.
59. Ferrer, R., Martin-Loeches, I., Phillips, G., et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 42:8 (2014), 1749–1755.
60. Barie, P.S., Hydo, L.J., Shou, J., et al. Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 6:1 (2005), 41–54.
61. Houck, P.M., Bratzler, D.W., Nsa, W., et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164:6 (2004), 637–644.
62. Iregui, M., Ward, S., Sherman, G., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122:1 (2002), 262–268.
63. Meehan, T.P., Fine, M.J., Krumholz, H.M., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278:23 (1997), 2080–2084.
64. Sterling, S.A., Miller, W.R., Pryor, J., et al. The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis. Crit Care Med 43:9 (2015), 1907–1915.
65. Alvarez-Lerma, F., Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 22:5 (1996), 387–394.
66. Ibrahim, E.H., Sherman, G., Ward, S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:1 (2000), 146–155.
67. Kollef, M.H., Sherman, G., Ward, S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:2 (1999), 462–474.
68. Kumar, A., Ellis, P., Arabi, Y., et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:5 (2009), 1237–1248.
69. Leibovici, L., Shraga, I., Drucker, M., et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:5 (1998), 379–386.
70. Luna, C.M., Vujacich, P., Niederman, M.S., et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:3 (1997), 676–685.
71. Montravers, P., Gauzit, R., Muller, C., et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 23:3 (1996), 486–494.
72. Mosdell, D.M., Morris, D.M., Voltura, A., et al. Antibiotic treatment for surgical peritonitis. Ann Surg 214:5 (1991), 543–549.
73. Paul, M., Shani, V., Muchtar, E., et al. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54:11 (2010), 4851–4863.
74. Johnson, M.T., Reichley, R., Hoppe-Bauer, J., et al. Impact of previous antibiotic therapy on outcome of gram-negative severe sepsis. Crit Care Med 39:8 (2011), 1859–1865.
75. Dortch, M.J., Fleming, S.B., Kauffmann, R.M., et al. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infect (Larchmt) 12:1 (2011), 15–25.
76. Fabian, T.C., Croce, M.A., Payne, L.W., et al. Duration of antibiotic therapy for penetrating abdominal trauma: a prospective trial. Surgery 112:4 (1992), 788–794 [discussion: 794–5].
77. Namias, N., Harvill, S., Ball, S., et al. Cost and morbidity associated with antibiotic prophylaxis in the ICU. J Am Coll Surg 188:3 (1999), 225–230.
78. Lotfi, C.J., Cavalcanti Rde, C., Costa e Silva, A.M., et al. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg 138:1 (2008), 74–80.
79. Kollef, M.H., Silver, P., Murphy, D.M., et al. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 108:6 (1995), 1655–1662.
80. Puzniak, L., Teutsch, S., Powderly, W., et al. Has the epidemiology of nosocomial candidemia changed?. Infect Control Hosp Epidemiol 25:8 (2004), 628–633.
81. Riccio, L.M., Popovsky, K.A., Hranjec, T., et al. Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections. Surg Infect (Larchmt) 15:4 (2014), 417–424.
82. Harbarth, S., Samore, M.H., Lichtenberg, D., et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 101:25 (2000), 2916–2921.
83. Velmahos, G.C., Toutouzas, K.G., Sarkisyan, G., et al. Severe trauma is not an excuse for prolonged antibiotic prophylaxis. Arch Surg 137:5 (2002), 537–541 [discussion: 541–2].
84. May, A.K., Fleming, S.B., Carpenter, R.O., et al. Influence of broad-spectrum antibiotic prophylaxis on intracranial pressure monitor infections and subsequent infectious complications in head-injured patients. Surg Infect (Larchmt) 7:5 (2006), 409–417.
85. Trouillet, J.L., Chastre, J., Vuagnat, A., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157:2 (1998), 531–539.
86. Chastre, J., Wolf, M., Fagon, J.Y., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA 290:19 (2003), 2588–2598.
87. Teshome, B., Vouri, S., Hampton, N., et al. Duration of broad-spectrum antimicrobials in the critically ill and the development of new resistance. Crit Care Med, 44(12s), 2016, 236.
88. Silva, B.N.G., Andriolo, R.B., Atallah, A.N., et al. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev(3), 2013 CD007934.
89. Sawyer, R.G., Claridge, A.B., Nathens, O.D., et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 372 (2015), 1996–2005.
90. Mazuski, J.E., Tessier, J.M., May, A.K., et al. The Surgical Infection Society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt) 18:1 (2017), 1–76.
91. Kalil, A.C., Metersky, M.L., Klompas, M., et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63:5 (2016), e61–e111.
92. Dellinger, R.P., Carlet, J.M., Masur, H., et al. Surviving sepsis campaign management guidelines committee: surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004), 858–873.
93. Dellinger, R.P., Levy, M.M., Carlet, J.M., et al. International Surviving Sepsis Campaign Guidelines Committee American Association of Critical-Care Nurses American College of Chest Physicians American College of Emergency Physicians Canadian Critical Care Society European Society of Clinical Microbiology and Infectious Diseases European Society of Intensive Care Medicine; European Respiratory Society International Sepsis Forum Japanese Association for Acute Medicine Japanese Society of Intensive Care medicine Society of Critical Care Medicine Society of Hospital Medicine Surgical Infection Society, World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 (2008), 296–327.
94. Dellinger, R.P., Levy, M.M., Carlet, J.M., et al. International Surviving Sepsis Campaign Guidelines Committee American Association of Critical-Care Nurses American College of Chest Physicians American College of Emergency Physicians Canadian Critical Care Society European Society of Clinical Microbiology and Infectious Diseases European Society of Intensive Care Medicine European Respiratory Society International Sepsis Forum Japanese Association for Acute Medicine Japanese Society of Intensive Care medicine Society of Critical Care Medicine Society of Hospital Medicine Surgical Infection Society, World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34 (2008), 17–60 [Erratum appears in Intensive Care Med 2008;34:783–5].
95. Dellinger, R.P., Levy, M.M., Rhodes, A., et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41 (2013), 580–637.
96. Dellinger, R.P., Levy, M.M., Rhodes, A., et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med 39 (2013), 165–228.
97. Rhodes, A., Evans, L.E., Alhazzani, W., et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45:3 (2017), 486–552.
98. Rhodes, A., Evans, L.E., Alhazzani, W., et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43 (2017), 304–377.
99. Levy, M.M., Rhodes, A., Phillips, G.S., et al. Surviving Sepsis Campaign: Association between performance metrics and outcomes in a 7.5 year study. Crit Care Med 43:3 (2015), 3–12.
100. Rhodes, A., Phillips, G., Beale, R., et al. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med 41 (2015), 1620–1628.
101. Dellinger, R.P., Schorr, C.A., Levy, M.M., A users’ guide to the 2016 surviving sepsis guidelines. Intensive Care Med 3 (2017), 299–303.
102. Dellinger, R.P., Schorr, C.A., Levy, M.M., A users’ guide to the 2016 surviving sepsis guidelines. Crit Care Med 45 (2017), 381–385.
103. The ARISE Investigators and the ANZICS Clinical Trial Group, Peake, S.L., Delaney, A., Bailey, M., et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:16 (2014), 1496–1506.
104. The ProCESS Investigators, Yealy, D.M., Kellum, J.A., Huang, D.T., et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:18 (2014), 1683–1693.
105. The ProMISe Investigators, Mouncey, P.R., Osborn, T.M., Power, S., et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372 (2015), 1301–1311.
106. Marik, P.E., Barma, M., Vahid, B., Does central venous pressure predict fluid responsiveness? A systemic review of the literature and the tale of seven mares. Chest 134 (2008), 172–178.
107. Marik, P.E., Cavallazzi, R., Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med 41 (2013), 1774–1781.
108. Bentzer, P., Griesdale, D.E., Boyd, J., et al. Will this hemodynamically unstable patient respond to a bolus of intravenous fluids?. JAMA 316 (2016), 1298–1309.
109. Monnet, X., Marik, P.E., Teboul, J.L., Prediction of fluid responsiveness: an update. Ann Intensive Care 6:111 (2016), 1–11.
110. Michard, F., Boussat, S., Chemla, D., et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 162 (2000), 134–138.
111. Yang, X., Du, B., Does pulse pressure variation predict fluid responsiveness in critically ill patients? A systematic review and meta-analysis. Crit Care, 18, 2014, 650.
112. Marik, P.E., Cavallazzi, R., Vasu, T., et al. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systemic review of the literature. Crit Care Med 37 (2009), 2642–2647.
113. Barbier, C., Loubieres, Y., Schmit, C., et al. Respiratory changes in inferior vena diameter are helpful in predicting fluid responsiveness in ventilated septic patients. Intensive Care Med 30 (2004), 1740–1746.
114. Viellard-Baron, A., Chergui, K., Rabiller, A., et al. Superior vena cava collapsibility as a gauge of volume status in ventilated septic patients. Intensive Care Med 30 (2004), 1734–1739.
115. Monnet, X., Rienzo, M., Osman, D., et al. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med 34 (2006), 1402–1407.
116. Cherpanath, T.G., Hirsch, A., Geerts, B.F., et al. Predicting fluid responsiveness by passive leg raising: a systematic review and meta-analysis of 23 clinical trials. Crit Care Med 44 (2016), 981–991.
117. Monnet, X., Marik, P., Teboul, J.L., Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med 42:12 (2016), 1935–1947.
118. Monnet, X., Osman, D., Ridel, C., et al. Predicting volume responsiveness by using the end-expiratory occlusion in mechanically ventilated intensive care unit patients. Crit Care Med 37 (2009), 951–956.
119. Muller, L., Toumi, M., Bousquet, P.J., et al. An increase in aortic blood flow after an infusion of 100 ml of colloid over 1 minute can predict fluid responsiveness: the Mini Fluid Challenge Study. Anesthesiology 115 (2011), 541–547.
120. Vincent, J.L., Weil, M.H., Fluid challenge revisited. Crit Care Med 34 (2006), 1333–1337.
121. Cecconi, M., Hofer, C., Teboul, J.L., et al. Fluid challenges in intensive care: the FENICE study, a global inception cohort study. Intensive Care Med 41 (2015), 1529–1537.
122. Gu, W.J., Wang, F., Bakker, J., et al. The effect of goal-directed therapy on mortality in patients with sepsis-earlier is better: a meta-analysis of randomized control trials. Crit Care, 18, 2014, 570.
123. Ho, B.C., Bellom, R., McGain, F., et al. The incidence and outcome of septic shock patients in the absence of early goal-directed therapy. Crit Care, 10, 2006, R80.
124. Chapman, M., Gattas, D., Suntharalingam, G., Why is early goal-directed therapy successful—is it the technology?. Crit Care 9 (2005), 307–308.
125. Jones, A.E., Unbundling early sepsis resuscitation. Ann Emerg Med 63:6 (2014), 654–655.
126. Lewis, R.J., Disassembling goal-directed therapy for sepsis. JAMA 303:8 (2010), 777–779.
127. Nguyen, H.B., Jaehne, A.K., Jayaprakash, N., et al. Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE. Crit Care, 20, 2016, 160.
128. Yu, H., Chi, D., Wang, S., et al. Effect of early goal-directed therapy on mortality in patients with severe sepsis or septic shock: a meta-analysis of randomized controlled trials. BMJ Open, 6, 2016, e008330.
129. Gupta, R.G., Hartigan, S.M., Kashiouris, M.G., et al. Early goal-directed resuscitation of patients with septic shock: current evidence and future directions. Crit Care, 19, 2015, 286.
130. Angus, D.C., Barnato, A.E., Bell, D., et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med 41 (2015), 1549–1560.
131. Coccolin, F., Sartelli, M., Catena, F., et al. Early goal-directed treatment versus standard care in the management of early septic shock: meta-analysis of randomized trials. J Trauma Acute Care Surg 81:5 (2016), 971–978.
132. Park, S.K., Shin, S.R., Hur, M., et al. The effect of early goal-directed therapy for treatment of severe sepsis or septic shock: a systemic review and meta-analysis. J Crit Care 38 (2017), 115–122.
133. Rivers, E.P., Yataco, A.C., Jaehne, A.K., et al. Oxygen extraction and perfusion markers in severe sepsis and septic shock: diagnostic, therapeutic and outcome implications. Curr Opin Crit Care 21 (2015), 381–387.
134. Cecconi, M., De Backer, D., Antonelli, M., et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 40 (2014), 1795–1815.
135. Eskesen, T.G., Wetterslev, M., Perner, A., Systematic review including re-analysis of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med 42 (2016), 324–332.
136. Walkey, A.J., Wiener, R.S., Lindenauer, P.K., Utilization patterns and outcomes associated with central venous catheter in septic shock: a population based study. Crit Care Med 41 (2013), 1450–1457.
137. Sondergaard, S., Parkin, G., Aneman, A., Central venous pressure: soon an outcome-associated matter. Curr Opin Anaesthesiol 29 (2016), 179–185.
138. Holst, L.B., Haase, N., Wetterslev, J., et al., The TRISS Trial Group and the Scandinavian Critical Care Trials Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371 (2014), 1381–1391.
139. Rygard, S.L., Holst, L.B., Wetterslev, J., et al., The TRISS Trial Group and the Scandanvian Critical Care Trials Group. Long-term outcomes in patients with septic shock transfused at lower versus a higher haemoglobin threshold: the TRISS randomized, multicenter clinical trial. Intensive Care Med 42 (2016), 1685–1694.
140. Dupuis, C., Sonneville, R., Adrie, C., et al. Impact of transfusion on patients with sepsis admitted to the intensive care unit: a systematic review and meta-analysis. Ann Intensive Care 7:5 (2017), 1–13.
141. Boulain, T., Garot, D., Vignon, P., et al. Prevalence of low central venous oxygen saturation in the first hours of intensive care unit admission and associated mortality in septic shock patients: a prospective multicentre study. Crit Care, 18(6), 2014, 609.
142. Pope, J.V., Jones, A.E., Gaieski, D.F., et al. Multicenter study of central venous oxygen saturation (ScVO2) as a predictor of mortality in patients with sepsis. Ann Emerg Med 55:1 (2010), 40–46.
143. De Backer, D., Creteur, J., Preiser, J.C., et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Care Med 166 (2002), 98–104.
144. Spronk, P.E., Ince, C., Gardien, M.J., et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360 (2002), 1395–1396.
145. Spronk, P.E., Zandstra, D.F., Ince, C., Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 8:6 (2004), 462–468.
146. Sakr, Y.L., Dubois, M.J., De Backer, D., et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32 (2004), 1825–1831.
147. Trzeciak, S., Dellinger, R.P., Parrillo, J.E., et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 49:1 (2007), 88–98.e2.
148. Brealey, D., Brand, M., Hargreaves, I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002), 219–223.
149. Fink, M.P., Bench-to-bedside review: cytopathic hypoxia. Crit Care 6 (2002), 491–499.
150. Crouser, E.D., Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4 (2004), 729–741.
151. Protti, A., Singer, M., Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care 10:228 (2006), 1–7.
152. Levy, R.J., Mitochondrial dysfunction, bioenergetics impairment, and metabolic down-regulation in sepsis. Shock 28:1 (2007), 24–28.
153. Ruggieri, A.J., Levy, R.J., Deutschman, C.S., Mitochondrial dysfunction and resuscitation in sepsis. Crit Care Clin 26 (2010), 567–575.
154. Mizock, B.A., Falk, J.L., Lactic acidosis in critical illness. Crit Care Med 20 (1992), 80–93.
155. Nguyen, B.H., Rivers, E.P., Knoblich, B.P., et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 32:8 (2004), 1637–1642.
156. Jones, A.E., Shapiro, N.I., Trzeciak, S., et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303 (2010), 739–746.
157. Jansen, T.C., van Bommel, J., Schoonderbeek, F.J., et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized control trial. Am J Respir Crit Care Med 182 (2010), 752–761.
158. Gu, W.J., Zhang, Z., Bakker, J., Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Intensive Care Med 41 (2015), 1862–1863.
159. Bakker, J., Gris, P., Coffernils, M., et al. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 171 (1996), 221–226.
160. Shapiro, N.I., Howell, M.D., Talmor, D., et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 45 (2005), 524–528.
161. Mikkelsen, M.E., Miltiades, A.N., Gaieski, D.F., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 37:5 (2009), 1670–1677.
162. Arnold, R.C., Shapiro, N.I., Jones, A.E., et al. Multi-center study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock 32 (2009), 36–39.
163. Puskarich, M.A., Trzeciak, S., Shapiro, N., et al. Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med 19:3 (2012), 252–258.
164. Casserly, B., Phillips, G.S., Schorr, C., et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med 43 (2015), 567–573.
165. Chertoff, J., Chisum, M., Simmons, L., et al. Prognostic utility of plasma lactate measured between 24 and 48 h after initiation of early goal-directed therapy in the management of sepsis, severe sepsis, and septic shock. J Intensive Care 4:13 (2016), 1–8.
166. Gladden, L.B., Lactate metabolism: a new paradigm for the third millennium. J Physiol 558:1 (2004), 5–30.
167. Levy, B., Lactate and the shock state: the metabolic view. Curr Opin Crit Care 12 (2006), 315–321.
168. Garcia-Alvarez, M., Marik, P., Bellomo, R., Sepsis-associated hyperlactatemia. Crit Care 18:503 (2014), 1–11.
169. Nguyen, H.B., Kuan, W.S., Batech, M., et al., The ATLAS (Asia Network to Regulate Sepsis care) Investigators. Outcome effectiveness of the severe sepsis resuscitation bundle with addition of lactate clearance as a bundle item: a multi-national evaluation. Crit Care 15:R229 (2011), 1–10.
170. Dubin, A., O Pozo, M., Casabella, C.A., et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care 13:R92 (2009), 1–8.
171. LeDoux, D., Astiz, M.E., Carpati, C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28:8 (2000), 2729–2732.
172. Thooft, A., Favory, R., Salgado, D.R., et al. Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care 15:R222 (2011), 1–8.
173. Xu, J.Y., Ma, S.Q., Pan, C., et al. A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study. Crit Care 19:130 (2015), 1–8.
174. Ince, C., Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care 19:S8 (2015), 1–13.
175. Varpula, M., Tallgren, M., Saukkonen, K., et al. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 31 (2005), 1066–1071.
176. Bai, X., Yu, W., Ji, W., et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care 18:532 (2014), 1–8.
177. Waechter, J., Kumar, A., Lapinsky, S., et al., The Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med 42:10 (2014), 2158–2168.
178. Asfar, P., Meziani, F., Hamel, J.F., et al., The SESPISPAM Investigators. High versus low blood-pressure target in patients with septic shock. N Engl J Med 370:17 (2014), 1583–1651.
179. Bourgoin, A., Leone, M., Delmas, A., et al. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 33:4 (2005), 780–786.
180. Jones, A.E., Brown, M.D., Trzeciak, S., et al., On Behalf of the Emergency Medicine Shock Research Network Investigators. The effect of quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med 36:10 (2008), 2734–2739.
181. Simpson, S.Q., Gaines, M., Hussein, Y., et al. Early goal-directed therapy for severe sepsis and septic shock: a living systematic review. J Crit Care 36 (2016), 43–48.
182. Puskarich, M.A., Trzeciak, S., Shapiro, N.I., et al. Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. Resuscitation 82 (2011), 1289–1293.
183. Cannon, C.M., Holthaus, C.V., Zubrow, M.T., et al. The GENESIS project (GEN-earlized Early Sepsis Intervnetion Strategies): a multicenter quality improvement collaborative. J Intensive Care Med 28 (2013), 355–368.
184. Ranzani, O.T., Monteiro, M.B., Ferreira, E.M., et al. Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock. Rev Bras Ter Intensiva 25 (2013), 270–278.
185. Dugas, A.F., Mackenhauer, J., Salciccioli, J.D., et al. Prevalence and characteristics of nonlactate and lactate expressors in septic shock. J Crit Care 27 (2012), 344–350.
186. Hernandez, G., Castro, R., Romero, C.I., et al. Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock?. J Crit Care, 26, 2011, 435.e9-14.
187. Park, J.S., Kim, S.J., Lee, S.W., et al. Initial low oxygen extraction ratio is related to severe organ dysfunction and high in-hospital mortality in severe sepsis and septic shock patients. J Emerg Med 49:3 (2015), 261–267.
188. Thomas-Rueddel, D.O., Poidinger, B., Weiss, M., et al. Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock. J Crit Care, 30, 2015, 439.
189. Eidelman, L.A., Putterman, D., Putterman, C., et al. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 275 (1996), 470–473.
190. Ebersoldt, M., Sharshar, T., Annane, D., Sepsis-associated delirium. Intensive Care Med 33 (2007), 941–950.
191. Heming, N., Mazeraud, A., Verdonk, F., et al. Neuroanatomy of sepsis-associated encephalopathy. Crit Care 21:65 (2017), 1–6.
192. Tauber, S., Eiffert, H., Bruck, W., et al. Septic encephalopathy and septic encephalitis. Expert Rev Anti Infect Ther 15:2 (2017), 121–132.
193. Tsuruta, R., Oda, Y., A clinical perspective of sepsis-associated delirium. J Intensive Care 4:18 (2016), 1–7.
194. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition. 2013, American Psychiatric Publishing, Arlington (VA).
195. Ely, E.W., Shintani, A., Truman, B., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291 (2004), 1753–1762.
196. McCusker, J., Cole, M., Abrahamowicz, M., et al. Delirium predicts 12-month mortality. Arch Intern Med 162:4 (2002), 457–463.
197. Leslie, D., Zhang, Y., Holford, T., et al. Premature death associated with delirium at 1-year follow-up. Arch Intern Med 165:14 (2005), 1657–1662.
198. Milbrandt, E.B., Deppen, S., Harrison, P.L., et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 32 (2004), 955–962.
199. Andrew, M., Freter, S., Rockwood, K., Incomplete functional recovery after delirium in elderly people: a prospective cohort study. BMC Geriatr, 5, 2005, 5.
200. Girard, T.D., Jackson, J.C., Pandharipande, P.P., et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 38 (2010), 1513–1520.
201. Pandharipande, P.P., Girard, T.D., Jackson, J.C., et al. Long-term cognitive impairment after critical illness. N Engl J Med 369 (2013), 1306–1316.
202. Barr, J., Fraser, G.L., Puntillo, K., et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41 (2013), 263–306.
203. Ely, E.W., Inouye, S.K., Bernard, G.R., et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 286 (2001), 2703–2710.
204. van Eijk, M.M., van Marum, R.J., Klijn, I.A., et al. Comparison of delirium assessment tools in a mixed intensive care unit. Crit Care Med 37 (2009), 1881–1885.
205. Ely, E.W., The ABCDEF bundle: science and philosophy of how ICU liberation serves patients and families. Crit Care Med 45:2 (2017), 321–330.
206. Marra, A., Ely, E.W., Pandharipande, P.P., et al. The ABCDEF bundle in critical care. Crit Care Clin 33:2 (2017), 225–243.
207. Barnes-Daly, M.A., Phillips, G., Ely, E.W., Improving hospital survival and reducing brain dysfunction at seven California community hospitals: implementing PAD guidelines via the ABCDEF bundle in 6,064 patients. Crit Care Med 45:2 (2017), 171–178.
208. Bouhemad, B., Nicolas-Robin, A., Arbelot, C., et al. Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med 41 (2015), 1004–1013.
209. Gonzalez, C., Begot, E., Dalmay, F., et al. Prognostic impact of left ventricular diastolic function in patients with septic shock. Ann Intensive Care 6:36 (2016), 1–8.
210. Calvin, J.E., Driedger, A.A., Sibbald, W.J., An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest 80 (1981), 579–586.
211. Parker, M.M., Shelhamer, J.H., Bacharach, S.L., et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100 (1984), 483–490.
212. Rudiger, A., Singer, M., Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:6 (2007), 1599–1608.
213. Suffredini, A.F., Fromm, R.E., Parker, M.M., et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321 (1989), 280–287.
214. Landesberg, G., Levin, P.D., Gilon, D., et al. Myocardial dysfunction in severe sepsis and septic shock: no correlation with inflammatory cytokines in real-life clinical setting. Chest 148:1 (2015), 93–102.
215. Sanfilippo, F., Corredor, C., Fletcher, N., et al. Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis. Intensive Care Med 41 (2015), 1004–1013.
216. Landesberg, G., Gilon, D., Meroz, Y., et al. Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J 33 (2012), 895–903.
217. Sevilla Berrios, R.A., O'Horo, J.C., Velagapudi, V., et al. Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: a systematic review and meta-analysis. J Crit Care 29 (2014), 495–499.
218. Pulido, J.N., Afessa, B., Masaki, M., et al. Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. Mayo Clin Proc 87:7 (2012), 620–628.
219. Huang, S.J., Nalos, M., McLean, A.S., Is early ventricular dysfunction or dilation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care 17:R96 (2013), 1–13.
220. Bessiere, F., Khenifer, S., Dubourg, J., et al. Prognostic value of troponins in sepsis: a meta-analysis. Intensive Care Med 39 (2013), 1181–1189.
221. Maeder, M., Fehr, T., Rickli, H., et al. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129:5 (2006), 1349–1366.
222. Annane, D., Vignon, P., Renault, A., et al., The CATS Study Group. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370 (2007), 676–684.
223. Hayes, M.A., Timmins, A.C., Yau, E.H., et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330 (1994), 1717–1722.
224. Vincent, J.L., The International Sepsis Forum's frontiers in sepsis: high cardiac output should be maintained in severe sepsis. Crit Care 7:4 (2003), 276–278.
225. Shaver, C.M., Chen, W., Janz, D.R., et al. Atrial fibrillation is an independent predictor of mortality in critically ill patients. Crit Care Med 43:10 (2015), 2104–2111.
226. Kuipers, S., Klein Klouwenberg, P.M.C., Cremer, O.L., Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care 18:6 (2014), 1–9.
227. Klein Klouwenberg, P.M.C., Frencken, J.F., Kuipers, S., et al. Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis: a cohort study. Am J Respir Care Med 195:2 (2017), 205–211.
228. Liu, W.C., Lin, W.Y., Lin, S.C., et al. Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation. Crit Care 20:373 (2016), 1–9.
229. Morelli, A., Ertmer, C., Westphal, M., et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310 (2013), 1683–1691.
230. Walkey, A.J., Evans, S.R., Winter, M.R., et al. Practice patterns and outcomes of treatments for atrial fibrillation during sepsis: a propensity-matched cohort study. Chest 149:1 (2016), 74–83.
231. Walkey, A.J., Quin, E.K., Winter, M.R., et al. Practice patterns and outcomes associated with use of anticoagulation among patients with atrial fibrillation during sepsis. JAMA Cardiol 1:6 (2016), 682–690.
232. January, C.T., Wann, L.S., Alpert, J.S., et al., The ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130:23 (2014), 2071–2104.
233. Heidenreich, P.A., Solis, P., Estes, N.A. 3rd, et al. 2016 ACC/AHA clinical performance and quality measures for adults with atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol 68:5 (2016), 525–568.
234. Barnett, A.S., Lewis, W.R., Field, M.E., et al. Quality of evidence underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society guidelines on the management of atrial fibrillation. JAMA Cardiol 2:3 (2017), 319–323.
235. De Backer, D., Aldecoa, C., Njimi, H., et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 40:3 (2012), 725–730.
236. Gamper, G., Havel, C., Arrich, J., et al. Vasopressors for hypotensive shock. Cochrane Database Syst Rev(2), 2016 CD003709.
237. De Backer, D., Biston, P., Devriendt, J., et al., SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:9 (2010), 779–789.
238. Avni, T., Lador, A., Lev, S., et al. Vasopressors for the treatment of septic shock: systematic review and meta-analysis. PLoS One, 10(8), 2015, e0129305.
239. Landry, D.W., Levin, H.R., Gallant, E.M., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95 (1997), 1122–1125.
240. Sharshar, T., Blanchard, A., Paillard, M., et al. Circulating vasopressin levels in septic shock. Crit Care Med 31 (2003), 1752–1758.
241. Russel, J.A., Walley, K.R., Singer, J., et al., The VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358 (2008), 877–887.
242. Russell, J.A., Walley, K.R., Gordon, A.C., et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 37 (2009), 811–818.
243. Russell, J.A., Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care 15:226 (2011), 1–19.
244. Gordon, A.C., Mason, A.J., Perkins, G.D., et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med 42 (2014), 1325–1333.
245. Gordon, A.C., Mason, A.J., Thirunavukkarasu, N., et al., The VANISH Investigators. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316:5 (2016), 509–518.
246. Curtis, N., Corapi, J., Roberts, R., et al. Rebranding of generic parenteral vasopressin: effect on clinician practices and perceptions. Am J Health Syst Pharm 74:3 (2017), 105–106.
247. Myburgh, J.A., Higgins, A., Jovanovska, A., et al., The CAT Study Investigators. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34 (2008), 2226–2234.
248. Morelli, A., Ertmer, C., Rehberg, S., et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care 12:R143 (2008), 1–11.
249. Morelli, A., Lange, M., Ertmer, C., et al. Short-term effects of phenylephrine on systemic and regional hemodynamics in patients with septic shock: a crossover pilot study. Shock 29 (2008), 446–451.
250. Gregory, J.S., Bonfiglio, M.F., Dasta, J.F., et al. Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 19:11 (1991), 1395–1400.
251. Vail, E., Gershengorn, H.B., Hua, M., et al. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA 317:14 (2017), 1433–1442.
252. ARDS Definition Task force, Ranieri, V.M., Rubenfeld, G.D., Thompson, B.T., et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 307:23 (2012), 2526–2533.
253. Acute Respiratory Distress Syndrome Network, Brower, R.G., Matthay, M.A., Morris, A., et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:18 (2000), 1301–1308.
254. Futier, E., Constantin, J.M., Paugam-Burtz, C., et al., IMPROVE Study Group. A trial of intraoperative low-tidal volume ventilation in abdominal surgery. N Engl J Med 369 (2013), 428–437.
255. Pinheiro de Oliveira, R., Hetzel, M.P., dos Anjos Silva, M., et al. Mechanical ventilation with high tidal volume induces inflammation in patients without lung disease. Crit Care, 14(2), 2010, R39.
256. Guerin, C., Reignier, J., Richard, J.C., et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368:23 (2013), 2159–2168.
257. Beitler, J.R., Shaeif, S., Montesi, S.B., et al. Prone positioning reduces mortality from acute respiratory distress syndrome in the low tidal volume era: a meta-analysis. Intensive Care Med 40 (2014), 332–341.
258. Papazian, L., Forel, J.M., Gacouin, A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363:12 (2010), 1107–1116.
259. Peek, G.J., Mugford, M., Tiruvoipati, R., et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicenter randomized controlled trial. Lancet 374 (2009), 1351–1363.
260. Casaer, M.P., Van den Berghe, G., Nutrition in the acute phase of critical illness. N Engl J Med 370:23 (2014), 1227–1236.
261. Alberda, C., Gramlich, L., Jones, N., et al. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med 35 (2009), 1728–1737.
262. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Rice, T.W., Wheeler, A.P., Thompson, B.T., et al. Initial trophic vs full enteral feeding in patients with acute lung injury. JAMA 307:8 (2012), 795–803.
263. Kuppinger, D.D., Rittler, P., Hartl, W.H., et al. Use of gastric residual volume to guide enteral nutrition in critically ill patients: a brief systematic review of clinical studies. Nutrition 29:9 (2013), 1075–1079.
264. Acosta-Escribano, J., Fernandez-Vivas, M., Carmona, T.G., et al. Gastric versus transpyloric feeding in severe traumatic brain injury: a prospective, randomized trial. Intensive Care Med 36 (2010), 1532–1539.
265. Alkhawaja, S., Martin, C., Butler, R.J., et al. Post-pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adults. Cochrane Database Syst Rev(8), 2015 CD008875.
266. Dissanaike, S., Shelton, M., Warner, K., et al. The risk for bloodstream infections is associated with increased parenteral caloric intake in patients receiving parenteral nutrition. Crit Care, 11, 2007, R114.
267. Casaer, M., Mesotten, D., Hermans, G., et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 365 (2011), 506–517.
268. Peter, J.V., Moral, J.L., Phillips-Hughes, J., A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients. Crit Care Med 33:1 (2005), 213–220.
269. Heyland, D., Muscedere, J., Wischmeyer, P.E., et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368:16 (2013), 1489–1497.
270. Andrews, P.J., Avenell, A., Noble, D.W., et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ, 342, 2011, d1542.
271. Pontes-Arruda, A., Martins, L.F., de Lima, S.M., et al. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT Study. Crit Care, 15, 2011, R144.
272. Manzanares, W., Dhaliwal, R., Jurewitsch, B., et al. Parenteral fish oil lipid emulsions in the critically ill: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr 38 (2014), 20–28.
273. Zhu, D., Zhang, Y., Li, S., et al. Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Intensive Care Med 40 (2014), 504–512.
274. Rochwerg, B., Alhazzani, W., Sindi, A., et al. Fluids in sepsis and septic shock group: fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161 (2014), 347–355.
275. Haase, N., Perner, A., Hennings, L.I., et al. Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ, 346, 2013, f839.
276. Finfer, S., Bellomo, R., Boyce, N., et al., The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350 (2004), 2247–2256.
277. Caironi, P., Tognoni, G., Masson, S., et al., ALBIOS Study Investigators. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370 (2014), 1412–1421.
278. Delaney, A.P., Dan, A., McCaffrey, J., et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 39 (2011), 386–391.
279. Rochwerg, B., Alhazzani, W., Sindi, A., et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161 (2014), 347–355.
280. Vincent, J.L., Navickis, R.J., Wilkes, M.M., Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 32 (2004), 2029–2038.
281. de Oliveira, F.S., Freitas, F.G., Ferreira, E.M., et al. Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock. J Crit Care 30 (2015), 97–101.
282. Acheampong, A., Vincent, J.L., A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care, 19, 2015, 251.
283. Malbrain, M.L., Marik, P.E., Witters, I., et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systemic review with suggestions for clinical practice. Anaesthesiol Intensive Ther 46 (2014), 361–380.
284. Boyd, J.H., Forbes, J., Nakada, T.A., et al. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39 (2011), 259–265.
285. Mehta, R.L., Pascual, M.T., Soroko, S., et al., PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 288:20 (2002), 2547–2553.
286. Martin, G.S., Moss, M., Wheeler, A.P., et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 33 (2005), 1681–1687.
287. Uhlig, C., Silva, P.L., Deckert, S., et al. Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care, 18, 2014, R10.
288. Noritomi, D.T., Soriano, F.G., Kellum, J.A., et al. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. Crit Care Med 37:10 (2009), 2733–2739.
289. Cooper, D.J., Walley, K.R., Wiggs, B.R., et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. Ann Intern Med 112 (1990), 492–498.
290. El-Solh, A.A., Jaoude, P.A., Porhomayon, J., Bicarbonate therapy in the treatment of septic shock: a second look. Intern Emerg Med 5 (2010), 341–347.
291. Honore, P.M., Jacobs, R., Hendrickx, I., et al. Prevention and treatment of sepsis-induced acute kidney injury: an update. Ann Intensive Care, 5(1), 2015, 51.
292. De Corte, W., Vuylsteke, S., De Waele, J.J., et al. Severe lactic acidosis in critically ill patients with acute kidney injury treated with renal replacement therapy. J Crit Care 29:4 (2014), 650–655.
293. Gaudry, S., Hajage, D., Schortgen, F., et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:2 (2016), 122–133.
294. Tonelli, M., Manns, B., Feller-Kopman, D., Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40 (2002), 875–885.
295. Boonen, E., Vervenne, H., Meersseman, P., et al. Reduced cortisol metabolism during critical illness. N Engl J Med 368:18 (2013), 1477–1488.
296. Cooper, M.S., Stewart, P.M., Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348 (2003), 727–734.
297. Sprung, C.L., Annane, D., Keh, D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:2 (2008), 111–124.
298. Keh, D., Trips, E., Marx, G., Effect of hydrocortisone on development of shock among patients with severe sepsis. JAMA 316:17 (2016), 1775–1785.
299. Gibbison, B., Lopez-Lopez, J., Higgins, J.P., et al. Corticosteroids in septic shock: a systematic review and network meta-analysis. Crit Care, 21, 2017, 78.
300. Inoue, S., Egi, M., Kotani, J., et al. Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic review. Crit Care, 17, 2013, R48.
301. Egi, M., Bellomo, R., Stachowski, E., et al. Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis. Am J Respir Crit Care Med 173:4 (2006), 407–413.
302. Kwon, S., Thompson, R., Dellinger, P., et al. Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg 257:1 (2013), 8–14.
303. Van den Berghe, G., Wouters, P., Weekers, F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345:19 (2011), 1359–1367.
304. NICE-SUGAR Study Investigators, Finfer, S., Chittock, D.R., Su, S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:13 (2009), 1283–1297.
305. Griesdale, D.E., de Souza, R.J., van Dam, R.M., et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180:8 (2009), 821–827.
306. May, A.K., Kauffmann, R.M., Collier, B.R., The place for glycemic control in the surgical patient. Surg Infect (Larchmt) 12:5 (2011), 405–418.
307. Kauffmann, R.M., Hayes, R.M., Jenkins, J.M., et al. Provision of balanced nutrition protects against hypoglycemia in the critically ill surgical patient. JPEN J Parenter Enteral Nutr 35:6 (2011), 686–694.
308. Dortsch, M.J., Mowery, N.T., Ozdas, A., et al. A computerized insulin infusion titration protocol improves glucose control with less hypoglycemia compared to a manual titration protocol in a trauma intensive care unit. JPEN J Parenter Enteral Nutr 32:1 (2008), 18–27.